1. Home
  2. KGEI vs ADVM Comparison

KGEI vs ADVM Comparison

Compare KGEI & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KGEI
  • ADVM
  • Stock Information
  • Founded
  • KGEI 2008
  • ADVM 2006
  • Country
  • KGEI United States
  • ADVM United States
  • Employees
  • KGEI N/A
  • ADVM N/A
  • Industry
  • KGEI
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KGEI
  • ADVM Health Care
  • Exchange
  • KGEI Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • KGEI 131.8M
  • ADVM 119.6M
  • IPO Year
  • KGEI N/A
  • ADVM 2014
  • Fundamental
  • Price
  • KGEI $5.46
  • ADVM $5.27
  • Analyst Decision
  • KGEI
  • ADVM Strong Buy
  • Analyst Count
  • KGEI 0
  • ADVM 6
  • Target Price
  • KGEI N/A
  • ADVM $27.83
  • AVG Volume (30 Days)
  • KGEI 30.9K
  • ADVM 286.5K
  • Earning Date
  • KGEI 11-12-2024
  • ADVM 11-04-2024
  • Dividend Yield
  • KGEI N/A
  • ADVM N/A
  • EPS Growth
  • KGEI 2.07
  • ADVM N/A
  • EPS
  • KGEI 0.48
  • ADVM N/A
  • Revenue
  • KGEI $54,654,000.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • KGEI $15.80
  • ADVM N/A
  • Revenue Next Year
  • KGEI $12.21
  • ADVM N/A
  • P/E Ratio
  • KGEI $11.06
  • ADVM N/A
  • Revenue Growth
  • KGEI 16.56
  • ADVM N/A
  • 52 Week Low
  • KGEI $2.84
  • ADVM $4.97
  • 52 Week High
  • KGEI $5.84
  • ADVM $29.70
  • Technical
  • Relative Strength Index (RSI)
  • KGEI 79.45
  • ADVM 31.23
  • Support Level
  • KGEI $4.95
  • ADVM $4.97
  • Resistance Level
  • KGEI $5.84
  • ADVM $6.07
  • Average True Range (ATR)
  • KGEI 0.25
  • ADVM 0.35
  • MACD
  • KGEI 0.09
  • ADVM -0.05
  • Stochastic Oscillator
  • KGEI 78.16
  • ADVM 14.93

About KGEI Kolibri Global Energy Inc. Common stock

Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. Its segments include the United States, Canada and Others. The company derives a majority of its revenue from the United States.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.

Share on Social Networks: